Radiotherapy of non-small-cell lung cancer in the era ofEGFRgene mutations and EGF receptor tyrosine kinase inhibitors

Future Oncology ◽

10.2217/fon.15.156 ◽

2015 ◽

Vol 11 (16) ◽

pp. 2329-2342 ◽

Author(s):

Ilaria Moschini ◽

Cristina Dell'Anna ◽

Pier Luigi Losardo ◽

Paola Bordi ◽

Nunziata D'Abbiero ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitors ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitors ◽

Egf Receptor ◽

Small Cell Lung ◽

Receptor Tyrosine Kinase Inhibitors

Download Full-text

EGF receptor tyrosine kinase inhibitors in the treatment of brain metastases from non-small-cell lung cancer

Expert Review of Anticancer Therapy ◽

10.1586/era.12.121 ◽

2012 ◽

Vol 12 (11) ◽

pp. 1429-1435 ◽

Author(s):

Marco Bartolotti ◽

Enrico Franceschi ◽

Alba Ariela Brandes

Keyword(s):

Lung Cancer ◽

Brain Metastases ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitors ◽

Egf Receptor ◽

Small Cell Lung ◽

Receptor Tyrosine Kinase Inhibitors

Download Full-text

408P Integrated chemotherapy with EGFR receptor tyrosine kinase inhibitors in patients with non-small cell lung cancer harboring EGFR mutation

Annals of Oncology ◽

10.1016/j.annonc.2020.10.402 ◽

2020 ◽

Vol 31 ◽

pp. S1402

Author(s):

J. Maevskaya ◽

K. Laktionov ◽

D. Yudin ◽

L. Vladimirova

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitors ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitors ◽

Egfr Mutation ◽

Small Cell Lung ◽

Receptor Tyrosine Kinase Inhibitors

Download Full-text

Risk of fatal pulmonary events in patients with advanced non-small-cell lung cancer treated with EGF receptor tyrosine kinase inhibitors: a comparative meta-analysis

Future Oncology ◽

10.2217/fon.15.16 ◽

2015 ◽

Vol 11 (7) ◽

pp. 1109-1122 ◽

Author(s):

Omar Abdel-Rahman ◽

Hesham Elhalawani

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitors ◽

Egf Receptor ◽

Meta Analysis ◽

Small Cell Lung ◽

Receptor Tyrosine Kinase Inhibitors

Download Full-text

Activation of the IGF1R pathway potentially mediates acquired resistance to mutant-selective 3rd-generation EGF receptor tyrosine kinase inhibitors in advanced non-small cell lung cancer

10.18632/oncotarget.8013 ◽

2016 ◽

Vol 7 (16) ◽

pp. 22005-22015 ◽

Author(s):

Ji Hyun Park ◽

Yun Jung Choi ◽

Seon Ye Kim ◽

Jung-Eun Lee ◽

Ki Jung Sung ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitors ◽

Egf Receptor ◽

Acquired Resistance ◽

Small Cell Lung ◽

Receptor Tyrosine Kinase Inhibitors

Download Full-text

Recent understanding of the molecular mechanisms for the efficacy and resistance of EGF receptor-specific tyrosine kinase inhibitors in non-small cell lung cancer

Expert Opinion on Therapeutic Targets ◽

10.1517/14728222.2012.697155 ◽

2012 ◽

Vol 16 (8) ◽

pp. 771-781 ◽

Author(s):

Asuka Nakata ◽

Noriko Gotoh

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitors ◽

Cell Lung Cancer ◽

Molecular Mechanisms ◽

Kinase Inhibitors ◽

Egf Receptor ◽

Small Cell Lung

Download Full-text

Gallic acid inhibition of Src-Stat3 signaling overcomes acquired resistance to EGF receptor tyrosine kinase inhibitors in advanced non-small cell lung cancer

10.18632/oncotarget.10581 ◽

2016 ◽

Vol 7 (34) ◽

pp. 54702-54713 ◽

Author(s):

Ai N.H. Phan ◽

Tuyen N.M. Hua ◽

Min-Kyu Kim ◽

Vu T.A. Vo ◽

Jong-Whan Choi ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitors ◽

Egf Receptor ◽

Acquired Resistance ◽

Small Cell Lung ◽

Stat3 Signaling ◽

Receptor Tyrosine Kinase Inhibitors

Download Full-text

Neoadjuvant treatment with tyrosine kinase inhibitors in patients with resectable non-small cell lung cancer

Journal of Thoracic Disease ◽

10.21037/jtd.2019.09.68 ◽

2019 ◽

Vol 11 (10) ◽

pp. 4092-4095

Author(s):

Fernando Franco ◽

Mariano Provencio

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitors ◽

Cell Lung Cancer ◽

Kinase Inhibitors ◽

Neoadjuvant Treatment ◽

Small Cell Lung

Download Full-text

Access to Tyrosine Kinase Inhibitors and Survival in Patients with Advanced EGFR+ and ALK+ Positive Non–small-cell Lung Cancer Treated in the Real-World

Clinical Lung Cancer ◽

10.1016/j.cllc.2021.01.019 ◽

2021 ◽

Author(s):

Bernardo H.L. Goulart ◽

Shasank Chennupati ◽

Catherine R. Fedorenko ◽

Scott D. Ramsey

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitors ◽

Cell Lung Cancer ◽

Kinase Inhibitors ◽

Small Cell Lung ◽

Download Full-text

P45.16 Adverse Event Burden of Oral Tyrosine Kinase Inhibitors in EGFR and ALK Metastatic Non-Small Cell Lung Cancer

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.08.484 ◽

2021 ◽

Vol 16 (10) ◽

pp. S1092

Author(s):

D. Riley ◽

N. Kaur ◽

A. Baglione ◽

R. Hall ◽

L. Barnes ◽

...

Keyword(s):

Lung Cancer ◽

Adverse Event ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitors ◽

Cell Lung Cancer ◽

Kinase Inhibitors ◽

Small Cell Lung

Download Full-text

Quantifying the sensitivities of EGF receptor (EGFR) tyrosine kinase inhibitors in drug resistant non-small cell lung cancer (NSCLC) cells using hydrogel-based peptide array

Biosensors and Bioelectronics ◽

10.1016/j.bios.2010.07.106 ◽

2010 ◽

Vol 26 (2) ◽

pp. 424-431 ◽

Author(s):

Gargi Ghosh ◽

Xiaoliang Yan ◽

Andrew G. Lee ◽

Stephen J. Kron ◽

Sean P. Palecek

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Kinase Inhibitors ◽

Egf Receptor ◽

Peptide Array ◽

Drug Resistant ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitors

Download Full-text